Back to search

Instrument Business Outlook Volume 31 - Issue 24

3 Apr 2023
Categories:
Instrument Business Outlook
Table of Contents
  • SDi Biopharma Instrumentation Market Report
  • Pittcon Returns as Organizers Announce Rebranding
    • Press Conferences and New Products
    • Other New Products
    • Software
  • IBO Sales Indexes See Mixed Results in 2022 as They Transition from COVID-19 Marketplace
    • Analytical Instruments Sales Index
      • Q4
      • FYE
    • Life Science Sales Index
      • Q4
      • FYE
    • End-Markets
    • Regions
    • Product Lines
    • 2022
    • Quarterly Forecasts
    • Full-Year Forecasts
  • Executive Briefing
    • FTC Reverses Ruling on GRAIL
    • Illumina and Icahn Issues Responses
    • Thermo Fisher Considers Pharma Services Expansion
    • Sartorius Makes Multi-Billion Deal
    • Sartorius Announces Management Changes
    • Divested PerkinElmer Business Names CEO
    • INTEGRA Enters NGS Prep Market
    • Calibre Scientific Buys Another UK Firm
    • LGC Buys Standards Company
    • SomaLogic Announced CEO and Board Changes
    • Enzo to Sell Clinical Business
    • Evident Announces New Transfer Date
    • Telesis Bio Reports Cash Shortage
  • Fourth Quarter Results: Agilent Technologies, Bruker, MilliporeSigma, Standard BioTools and Tecan
    • Agilent Begins Fiscal 2023 with Growth Across Businesses
    • Bruker Finishes 2022 with Solid Revenue Growth
      • Q4
      • FYE
    • MilliporeSigma Q4 and FY22 Article
      • Q4
      • FYE
    • Standard BioTools Finishes 2022 with Declines Across its Businesses
      • Q4
      • FYE
    • High Demand for Tecan’s Base Business Leads to Annual Growth
  • IBO Stock Indexes Perform Well Despite Challenges in the Macroeconomy
    • Laboratory Instruments and Product Stock Index
    • Diversified Instrumentation Stock Index
    • International Stocks
  • Market Profile: Buoyancy Activated Cell Sorting (BACS)
    • Leading Vendors
    • Largest Markets
    • Kit Cost
  • Industry Watch
    • Government & Water: PFAS Regulations Proposed
    • Biopharma: Review of 2022 R&D
    • Chemical: M&A Activity Falls in 2022
  • Region Watch
    • China: Science Agency Overhaul Announced
    • India: Pharma Safety Shutdowns
    • UAE: New Genomics Strategy
  • News
    • Sequencing
      • Company News
      • Product Introductions
      • Sales & Orders of Note
    • MS, LC/MS & GC/MS
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Informatics
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
  • Bottom Line
Attachments
  • IBO 033123 Issue.pdf